Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$3.40B-41.82%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Edmond Scanlon
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Employees
- 19,420
- Beta
- 0.61
- Country
- IE
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 4.26
Financials
Revenue
$3.40B-41.8%Net Income
$287.60M+10.3%EBITDA
$569.19M+16.5%Free Cash Flow
$264.35M+100.4%EPS (diluted)
$1.78+20.3%Shares Outstanding (diluted)
161.04M-8.3%Operating Expenses
$0.00Cash & Debt
$455.11MReturn of Capital
$335.94MDividend per Share
$0.53Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.76B | $658.50M | $4.00 |
| 2024 | $6.93B | $734.40M | $4.25 |
| 2023 | $8.02B | $728.10M | $4.10 |
| 2022 | $8.77B | $606.50M | $3.42 |
| 2021 | $7.35B | $763.00M | $4.31 |
| 2020 | $6.95B | $554.10M | $3.13 |
| 2019 | $7.24B | $566.50M | $3.20 |
| 2018 | $6.61B | $540.50M | $3.06 |
| 2017 | $6.41B | $588.50M | $3.34 |
| 2016 | $6.13B | $533.10M | $3.03 |
| 2015 | $6.10B | $525.40M | $2.99 |
| 2014 | $5.76B | $479.90M | $2.73 |
| 2013 | $5.84B | $84.40M | $0.48 |
| 2012 | $5.85B | $260.70M | $1.48 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from KRYAY's reported EPS growth of 7.9% a year over 13 years.
- EPS in 5 years
- $5.85
- Implied price
- $111.20
- Return from $101.63
- 1.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $55.29 — -45.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| -2.1% | -14.4% | -10.7% | -7.6% | -4.9% | -2.4% |
| 2.9% | -10.0% | -6.2% | -2.9% | -0.0% | 2.6% |
| 7.9% | -5.6% | -1.6% | 1.8% | 4.8% | 7.6% |
| 12.9% | -1.3% | 2.9% | 6.5% | 9.7% | 12.5% |
| 17.9% | 3.1% | 7.5% | 11.3% | 14.6% | 17.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120-5.26%Social Signal Score
Mentions (3)
- Newsseekingalpha.com·2d ago·Positive
Kerry Group plc (KRYAY) Analyst/Investor Day Transcript Kerry Group plc (KRYAY) Analyst/Investor Day Transcript
View source ↗ - Newsmarketbeat.com·4d ago·Neutral
Kerry Group Targets 20%-21% Margins as Biotech Fuels Taste and Nutrition Growth Kerry Group LON: KYGA said it is positioning its technology portfolio, biotechnology capabilities and customer-focused application expertise to capture growing food and beverage innovation and renovation opportunities, particularly as consumers demand healthier, more affordable and differentiated products.
View source ↗ - Newszacks.com·40d ago·Positive
All You Need to Know About Kerry Group (KRYAY) Rating Upgrade to Buy Kerry Group (KRYAY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$15,001 - $50,000
- Daniel Goldmanhouse · NY10 · disclosed Mar 20, 2023 (21d later)Buy$15,001 - $50,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.